Metropolis Healthcare Ltd - Stock Valuation and Financial Performance

BSE: 542650 | NSE: METROPOLIS | Hospital & Healthcare Services | Small Cap

Metropolis Health. Share Price

1,699.95 -25.80 -1.50%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Metropolis Health.

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Semi Strong

Metropolis Healthcare stock performance -

mw4me loader
P/E Ratio (CD):
70.88
Market Cap:
8,843.8 Cr.
52-wk low:
1,181.1
52-wk high:
1,828.7

Is Metropolis Healthcare Ltd an attractive stock to invest in?

1. Is Metropolis Healthcare Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Metropolis Healthcare Ltd is a good quality company.

2. Is Metropolis Healthcare Ltd undervalued or overvalued?

The key valuation ratios of Metropolis Healthcare Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Metropolis Healthcare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Metropolis Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Metropolis Health.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Metropolis Healthcare Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 0%15.7%23.4%31%27.4%28.6%28.3%31.3%23.8%14.9%-
Value Creation
Index
NA0.20.71.31.01.01.11.30.80.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 04555245456477618569981,2281,1481,159
Sales YoY Gr.-NA15.2%4%18.8%17.6%12.5%16.5%23.1%-6.5%-
Adj EPS 011.91619.620.924.125.236.239.827.924.4
YoY Gr.-NA34.9%22.5%6.4%15.6%4.3%43.8%9.9%-29.8%-
BVPS (₹) 070.453.465.183.282.9103136.6170.9191.5209.6
Adj Net
Profit
060.979.597.4104121127185203143125
Cash Flow from Ops. 069.788.210210490.2215249253247-
Debt/CF from Ops. 00.20.1000.20010.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA12.2%10.3%-6.5%
Adj EPS NA6%3.6%-29.8%
BVPSNA18.1%23%12.1%
Share Price - - -6.5% 41.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
016.925.433.128.129.12730.125.615.312.2
Op. Profit
Mgn %
025.926.228.4282727.829.328.325.723.5
Net Profit
Mgn %
014.916.818.917.216.414.918.616.612.510.8
Debt to
Equity
000000000.30.1-
Working Cap
Days
00828216021818712711615346
Cash Conv.
Cycle
002218233318-8-927

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 10.27%

Return on Equity has declined versus last 3 years average to 12.10%

Net Profit has been subdued in last 3 years 3.56%

Sales growth is not so good in last 4 quarters at -0.98%

Latest Financials - Metropolis Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) 24.2 24.4
TTM Sales (₹ Cr.) 1,076 1,159
BVPS (₹.) 198.9 209.6
Reserves (₹ Cr.) 1,009 1,064
P/BV 8.68 8.24
PE 71.30 70.88
From the Market
52 Week Low / High (₹) 1181.05 / 1828.70
All Time Low / High (₹) 904.85 / 3579.00
Market Cap (₹ Cr.) 8,844
Equity (₹ Cr.) 10.3
Face Value (₹) 2
Industry PE 83.6

Management X-Ray of Metropolis Health.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *3.302.671.181.181.181.181.181.181.181.18
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Metropolis Health.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales4555245456477618569981,2281,148
Operating Expenses 337388391469557619708883857
Manufacturing Costs211820293035466361
Material Costs129143135146174204252276253
Employee Cost 95116128147176190199233253
Other Costs 92111108147177190211310290
Operating Profit 118136153178204237290346291
Operating Profit Margin (%) 25.8%26.0%28.2%27.6%26.8%27.7%29.0%28.1%25.4%
Other Income 62226889122017
Interest 2224413122532
Depreciation 212117192039466389
Exceptional Items 0-8000-250160
Profit Before Tax 101128160164187169244293188
Tax 334653526341617944
Profit After Tax 6882107112124128183215143
PAT Margin (%) 14.9%15.6%19.7%17.3%16.2%14.9%18.4%17.5%12.5%
Adjusted EPS (₹)11.914.820.521.023.925.235.841.927.9
Dividend Payout Ratio (%)0%104%49%0%55%32%22%19%29%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 361265323413416521698874981
Share Capital 101010101010101010
Reserves 351255314404406511688864971
Minority Interest2320211412122
Debt7311180025979
Long Term Debt730000015929
Short Term Debt0000180010050
Trade Payables34383635438511110394
Others Liabilities 4365131346325322249507554
Total Liabilities 4683915128108039301,0591,7451,710

Fixed Assets

Gross Block2602732202462713664381,2231,375
Accumulated Depreciation1071251739587095165255
Net Fixed Assets1531482022072132963431,0591,121
CWIP 0110630620
Investments 170801421023314101615
Inventories181814212624415145
Trade Receivables767780101137128123135122
Cash Equivalents 294341608021042016793
Others Assets222532318308253123311296
Total Assets 4683915128108039301,0591,7451,710

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 708810210490215249253247
PBT 101128160164187169244293188
Adjustment 169-32122837759104
Changes in Working Capital -17-3-4-23-5128-15-167
Tax Paid -32-47-51-58-67-64-57-83-52
Cash Flow From Investing Activity -5691-86235-10562-73847
Capex -24-13-16-18-23-36-28-31-52
Net Investments -35104-371756-7385-8093
Others 3-1-333345-6276
Cash Flow From Financing Activity -10-166-17-87-118-55-33163-292
Net Proceeds from Shares 0000-3323420
Net Proceeds from Borrowing -60-400-1801590
Interest Paid -2-1000-41-7-18-27
Dividend Paid -1-840-53-67-8-41-41-41
Others 0-81-13-34-48-21-1961-224
Net Cash Flow 413-119755278-3222
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)18.7726.1636.4730.3829.8227.2130.0727.3115.46
ROCE (%)27.4740.0654.2845.2244.7737.7941.634.3919.83
Asset Turnover Ratio0.971.221.210.980.940.9910.880.66
PAT to CFO Conversion(x)1.031.070.950.930.731.681.361.181.73
Working Capital Days
Receivable Days615353515756463841
Inventory Days151311101111121415
Payable Days96921008982114142141142

Metropolis Healthcare Ltd Stock News

Metropolis Healthcare Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Metropolis Health. on 28-Mar-2024 16:01 is ₹1,700.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Metropolis Health. stood at ₹8,843.8.
The latest P/E ratio of Metropolis Health. as of 28-Mar-2024 16:01 is 71.30.
The latest P/B ratio of Metropolis Health. as of 28-Mar-2024 16:01 is 8.68.
The 52-week high of Metropolis Health. is ₹1,828.7 and the 52-week low is ₹1,181.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Metropolis Health. is ₹1,076 ( Cr.) .

About Metropolis Healthcare Ltd

Metropolis Healthcare Limited is one of leading and renowned Indian diagnostics companies. The company owns a chain of diagnostic ce9ntres across India, South Asia, Africa and the Middle East. Over the years, Metropolis has carved a niche for itself. The company enjoys a loyal customer base, reflecting its strength as a brand offering superior diagnostic tests and services.

With its widespread operational network, Metropolis offers a comprehensive range of clinical laboratory tests and profiles. These tests and profiles are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease. Metropolis plays a pivotal role in raising the bar of diagnostic accuracy, technological equipment, customer experience and research-driven empathetic service in the industry.

Business area of the company

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease or disorder as well as wellness profiles that are used for health and fitness screening. It classifies its tests into ‘routine’ tests such as blood chemistry analyses, blood cell counts and urine examination; ‘semi-specialized’ tests such as thyroid function tests, viral and bacterial cultures, histology, cytology and infectious disease tests; and ‘specialized’ tests such as tests for coagulation studies, autoimmunity tests, cytogenetics and molecular diagnostics. It is focused on providing reliable test results as well as value-added services such as home collection of specimens and online access to test reports. It also offers customized wellness packages to its institutional customers as per their requirement.

Services

  • Pathology Testing Services
  • Corporate Wellness
  • Lab in Hospitals
  • Clinical Research Services

Awards

FY2018-19

  • The Global Reference Laboratory of Metropolis holds accreditation from the College of American Pathologists (CAP) since 2005 which is the gold standard in accreditations in industry, globally.
  • Metropolis Healthcare was awarded Iconic Pathology Lab Award by Mid-Day Health & Wellness Awards in September 2018
  • Metropolis received the ‘Best Diagnostic Laboratory’ in India award at the Women’s Health Conference 2019
  • Metropolis was awarded special jury mention for “Service Excellence (Diagnostic Centre)” by FICCI at the Healthcare Excellence Awards 2018
  • Metropolis Healthcare won the Best Temperature Controlled Project of the year at the Cold Chain Summit Awards held in Mumbai, 2018
  • Metropolis Healthcare honored for Excellence in Customer Service & Delivery at the Home Healthcare Summit & Awards 2018
  • Company was awarded for “Best in Health and Fitness” in the Digital Campaign Awards by LH Insights 2018.

FY2019-20

  • Accorded as the Most Admired Healthcare Company of The Year - February 2020
  • Won the award for Best It Practices at the Data Center Summit 2019 - October 2019
  • Awarded as the Best Patient Experience Team Of The Year Award at PEXA Awards 2019, in Delhi - December 2019
  • Won the Healthcare Leadership Award, at the Uttar Pradesh Healthcare Leadership Awards 2019 held at Lucknow - October 2019
  • Bagged Excellence In Logistics award at the CII SCALE Awards 2019 - Supply Chain & Logistics Excellence Awards organised by Confederation of Indian Industries - December 2019
  • Awarded the Best It Enabled Pathology Chain Award during the 4th Digital Innovation Health Summit and CIO Awards at Kolkata
  • Won a special mention as the Best Performance-Driven Digital Campaign Award at the InkSpell Drivers of Digital Awards 2019 - December 2019
  • Conferred the Best Logistics Network Optimization & Best Use Of Technology In Logistics awards announced at the 5th Asian Supply Chain Thought Leadership Summit & Awards in Mumbai - November 2019

Major Events & Milestones

  • 2002: First major acquisition by company of Sudharma.
  • 2004: The company was accredited by National Accreditation Board for Testing and Calibration Laboratories (Department of Science & Technology, India).
  • 2005: The company received accreditation from The College of American Pathologists.
  • 2006: Investment by The Western India Trustee and Executor company in company.
  • 2006: Acquisition of Lister Laboratory and Research Centre Private Limited in Chennai.
  • 2007: Acquisition of Desai Clinical Laboratory in Surat.
  • 2008: Acquisition of R.V Diagnostics & Healthcare Center Private Limited in Bangalore.
  • 2010: Investment by Foxcreek Investment Limited in company.
  • 2012: Acquisition of Micron Laboratories in Mumbai.
  • 2012: Incorporation of subsidiary in Mauritius.
  • 2013: Establishment of GRL in Mumbai.
  • 2014: Acquisition of subsidiary in Ghana.
  • 2015: Investment by CA Lotus Investments in company.
  • 2015: Incorporation of subsidiary in Uganda.
  • 2015: Incorporation of branch office in Zambia.
  • 2017: Acquisition of Sanjeevani Pathology Laboratory in Rajkot.
  • 2018: 2018 Public-Private partnership agreement executed with National AIDS Control Organisation, Government of India.
  • 2018: Scheme of Amalgamation 2018.
  • 2018: Incorporation of subsidiary in Tanzania.
  • 2020: Metropolis Healthcare executes pact to acquire 51% stake in Shraddha Diagnostic Centre
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.